Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nayanendu Saha

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
International Journal of Molecular Sciences|April 14, 2026
Characterization of the D8P1C1 Anti-ADAM17 Inhibitory Monoclonal Antibody and Generation of Its Bispecific T-Cell Engager DerivativeNayanendu Saha, Sang Gyu Lee, Elisa de Stanchina, et al.
International Journal of Molecular Sciences|October 13, 2021
The Ephb2 Receptor Uses Homotypic, Head-to-Tail Interactions within Its Ectodomain as an Autoinhibitory Control MechanismYan Xu, Dorothea Robev, Nayanendu Saha, et al.
Journal of Cell Science|October 31, 2012
Antibodies binding the ADAM10 substrate recognition domain inhibit Eph functionLakmali Atapattu, Nayanendu Saha, Carmen Llerena, et al.
Microorganisms|December 23, 2023
The Angiopoietin Signaling Pathway Is Involved in Inflammatory Processes in Hospitalized COVID-19 PatientsRachelle P Mendoza, Amir Momeni, Nayanendu Saha, et al.
Frontiers in Oncology|February 12, 2026
Inhibition of colorectal cancer progression through conformation-specific targeting of ADAM10 metalloproteasePargol Mashati, Dan Sun, Eduardo Garcia Reino, et al.
Translational Oncology|November 12, 2021
Inhibitory monoclonal antibody targeting ADAM17 expressed on cancer cellsNayanendu Saha, Kai Xu, Zhongyu Zhu, et al.
Cell|October 22, 2005
Adam meets Eph: an ADAM substrate recognition module acts as a molecular switch for ephrin cleavage in transPeter W Janes, Nayanendu Saha, William A Barton, et al.
Cancers|July 9, 2022
Preferential Antibody and Drug Conjugate Targeting of the ADAM10 Metalloprotease in TumoursHengkang Yan, Mary E Vail, Linda Hii, et al.
Cell|December 12, 2017
Structural Basis for Regulated Proteolysis by the α-Secretase ADAM10Tom C M Seegar, Lauren B Killingsworth, Nayanendu Saha, et al.
Heliyon|June 7, 2021
Ephrin-A1 and the sheddase ADAM12 are upregulated in COVID-19Rachelle Mendoza, Nayanendu Saha, Amir Momeni, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
International Journal of Molecular Sciences|April 14, 2026
Characterization of the D8P1C1 Anti-ADAM17 Inhibitory Monoclonal Antibody and Generation of Its Bispecific T-Cell Engager DerivativeNayanendu Saha, Sang Gyu Lee, Elisa de Stanchina, et al.
International Journal of Molecular Sciences|October 13, 2021
The Ephb2 Receptor Uses Homotypic, Head-to-Tail Interactions within Its Ectodomain as an Autoinhibitory Control MechanismYan Xu, Dorothea Robev, Nayanendu Saha, et al.
Journal of Cell Science|October 31, 2012
Antibodies binding the ADAM10 substrate recognition domain inhibit Eph functionLakmali Atapattu, Nayanendu Saha, Carmen Llerena, et al.
Microorganisms|December 23, 2023
The Angiopoietin Signaling Pathway Is Involved in Inflammatory Processes in Hospitalized COVID-19 PatientsRachelle P Mendoza, Amir Momeni, Nayanendu Saha, et al.
Frontiers in Oncology|February 12, 2026
Inhibition of colorectal cancer progression through conformation-specific targeting of ADAM10 metalloproteasePargol Mashati, Dan Sun, Eduardo Garcia Reino, et al.
Translational Oncology|November 12, 2021
Inhibitory monoclonal antibody targeting ADAM17 expressed on cancer cellsNayanendu Saha, Kai Xu, Zhongyu Zhu, et al.
Cell|October 22, 2005
Adam meets Eph: an ADAM substrate recognition module acts as a molecular switch for ephrin cleavage in transPeter W Janes, Nayanendu Saha, William A Barton, et al.
Cancers|July 9, 2022
Preferential Antibody and Drug Conjugate Targeting of the ADAM10 Metalloprotease in TumoursHengkang Yan, Mary E Vail, Linda Hii, et al.
Cell|December 12, 2017
Structural Basis for Regulated Proteolysis by the α-Secretase ADAM10Tom C M Seegar, Lauren B Killingsworth, Nayanendu Saha, et al.
Heliyon|June 7, 2021
Ephrin-A1 and the sheddase ADAM12 are upregulated in COVID-19Rachelle Mendoza, Nayanendu Saha, Amir Momeni, et al.
Pageof 3